Literature DB >> 9865430

Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.

B G Sleckman1, P M Mauch, R F Ambinder, R Mann, G S Pinkus, M E Kadin, B Sherburne, A Perez-Atayde, I Thior, N Mueller.   

Abstract

Risk factors suggestive of relatively late exposure to EBV have been consistently associated with Hodgkin's disease (HD) in younger adults. In addition, evidence of EBV infection has been found in the Reed-Sternberg cells themselves in about one-third to one-half of all HD cases. However, no study yet published has correlated these childhood social environment risk factors with the presence of EBV in Hodgkin's tumor cells. We examined whether EBV-positive HD occurs in those patients whose childhood environment would predispose them to relatively late exposure to EBV. The study population consisted of 102 cases of mixed cellularity (MC; n = 25) or nodular sclerosing (n = 77) HD. Samples that tested positive for either EBV-encoded RNA or latent membrane protein or both were considered EBV-positive. Of the 102 cases, 83 completed a questionnaire regarding childhood social environment. The association with EBV-positivity was estimated by the odds ratio (OR) with 95% confidence intervals (CI). Twenty-two percent of the cases were EBV-positive. These cases were more likely to be MC (OR, 6.2; CI, 2.3-16.3) and male (OR, 3.4; CI, 1.3-9.0). History of infectious mononucleosis (IM) was not predictive of EBV-positivity, with only 3 of 14 such patients being EBV-positive (P = 0.82). Contrary to our hypothesis, no association between EBV and childhood environment risk factors was identified. The association of EBV with MC histology and male gender agrees with previous reports. The most intriguing finding was the dissociation between IM history and EBV-positivity, in that almost all of the cases with a history of IM were EBV-negative.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865430

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

Review 1.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

Review 2.  Relevance of the Measles Virus Expression in Cancer - an Update.

Authors:  Daniel Benharroch; Samuel Ariad; Noa Tadmor; Karen Nalbandyan; Irena Lazarev
Journal:  Pathol Oncol Res       Date:  2016-06-10       Impact factor: 3.201

Review 3.  Epstein-Barr virus and Hodgkin's disease.

Authors:  L M Weiss
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

4.  Maternal and perinatal factors associated with hospitalised infectious mononucleosis in children, adolescents and young adults: record linkage study.

Authors:  Imran Mahmud; Omar A Abdel-Mannan; Clare J Wotton; Michael J Goldacre
Journal:  BMC Infect Dis       Date:  2011-02-28       Impact factor: 3.090

5.  Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.

Authors:  F E Alexander; R F Jarrett; D Lawrence; A A Armstrong; J Freeland; D A Gokhale; E Kane; G M Taylor; D H Wright; R A Cartwright
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

6.  Measles virus: evidence of an association with Hodgkin's disease.

Authors:  D Benharroch; Y Shemer-Avni; Y-Y Myint; A Levy; E Mejirovsky; I Suprun; Y Shendler; I Prinsloo; S Ariad; B Rager-Zisman; M Sacks; J Gopas
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

7.  Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.

Authors:  Linghui Zhou; Yujiao Deng; Na Li; Yi Zheng; Tian Tian; Zhen Zhai; Si Yang; Qian Hao; Ying Wu; Dingli Song; Dai Zhang; Jun Lyu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2019-10-22       Impact factor: 17.388

Review 8.  An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.

Authors:  Michael J Wells; Steven Jacobson; Paul H Levine
Journal:  Infect Agent Cancer       Date:  2019-11-05       Impact factor: 2.965

Review 9.  Does the measles virus contribute to carcinogenesis? - a review.

Authors:  Daniel Benharroch; Jacob Gopas; Samuel Ariad
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.